Precision Optics Corporation (POCI) Cash from Investing Activities (2010 - 2026)
Precision Optics Corporation (POCI) reported Cash from Investing Activities of $49492.0 for Q1 2026, up 155.14% year-over-year from $19397.7 in Q1 2025, and up 151.37% quarter-over-quarter from -$96342.0 in Q4 2025.
Precision Optics Corporation (POCI) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has 17 years of Cash from Investing Activities data on file, last reported at $49492.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $49492.0, up 155.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$432275.0 (down 167.43% YoY), and the FY2025 annual result was -$233473.0, up 20.56% from the prior year.
- Cash from Investing Activities advanced to $49492.0 in Q1 2026 per POCI's latest filing, from -$96342.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $96587.0 in Q2 2022 and troughed at -$301789.0 in Q3 2025.
- A 5-year average of -$61361.1 and a median of -$31986.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities plunged 13626.74% in 2024, then jumped 155.14% in 2026.
- A 5-year view of Cash from Investing Activities shows it stood at -$8463.0 in 2022, then tumbled by 1403.66% to -$127255.0 in 2023, then soared by 74.86% to -$31986.0 in 2024, then sank by 201.2% to -$96342.0 in 2025, then surged by 151.37% to $49492.0 in 2026.
- Business Quant data shows POCI's Cash from Investing Activities at $49492.0 in Q1 2026, -$96342.0 in Q4 2025, and -$301789.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Precision Optics Corporation | 44.43 Mn | 33.75 Mn | 2.06 Mn | 49,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,492.00 |
| Mar 31, 2026 | 49,492.00 |
| Dec 31, 2025 | -96,342.00 |
| Dec 31, 2025 | -96,342.00 |
| Sep 30, 2025 | -301,789.00 |
| Sep 30, 2025 | -301,789.00 |
| Jun 30, 2025 | -83,636.00 |
| Jun 30, 2025 | -83,636.00 |
| Mar 31, 2025 | -89,752.00 |
| Mar 31, 2025 | -89,752.00 |
| Dec 31, 2024 | -31,986.00 |
| Dec 31, 2024 | -31,986.00 |
| Sep 30, 2024 | -28,099.00 |
| Sep 30, 2024 | -28,099.00 |
| Jun 30, 2024 | -11,805.00 |
| Jun 30, 2024 | -11,805.00 |
| Mar 31, 2024 | -111,306.00 |
| Mar 31, 2024 | -111,306.00 |
| Dec 31, 2023 | -127,255.00 |
| Dec 31, 2023 | -127,255.00 |